The promotion of cartilage defect repair using adenovirus mediated Sox9 gene transfer of rabbit bone marrow mesenchymal stem cells

Biomaterials

Volumn 32, Issue 16, 2011, Pages 3910-3920

  Cao, Lei ^a   Yang, Fei ^a   Liu, Guangwang ^a   Yu, Degang ^a   Li, Huiwu ^a   Fan, Qiming ^a   Gan, Yaokai ^a   Tang, Tingting ^a   Dai, Kerong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Animal model; Cartilage tissue engineering; Gene transfer; Stem cell

Indexed keywords

ADENOVIRAL VECTORS; ANIMAL MODEL; ARTICULAR CARTILAGE REPAIR; BONE MARROW MESENCHYMAL STEM CELLS; CARTILAGE DEFECTS; CARTILAGE TISSUE ENGINEERING; CARTILAGE TISSUES; CHONDROGENESIS; CHONDROGENIC; CHONDROGENIC DIFFERENTIATION; EXTRACELLULAR MATRICES; HYALINE CARTILAGE; IMMUNOHISTOCHEMISTRY; IN-VITRO; IN-VIVO; MARKER GENES; MATRIX; RABBIT MODELS; REAL-TIME PCR; TOLUIDINE BLUE;

ANIMALS; BACTERIOPHAGES; BONE; CELL CULTURE; DEFECTS; GENE EXPRESSION; GENE TRANSFER; LIGAMENTS; MONOLAYERS; PHOTOMASKS; POLYMERASE CHAIN REACTION; REPAIR; SCAFFOLDS (BIOLOGY); STEM CELLS;

CARTILAGE;

ADENOVIRUS VECTOR; DYE; SAFRANIN O; TOLONIUM CHLORIDE; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BONE MARROW CELL; CARTILAGE INJURY; CELL DIFFERENTIATION; CHONDROGENESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HYALINE CARTILAGE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; REAL TIME POLYMERASE CHAIN REACTION; STAINING; TISSUE ENGINEERING; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; BONE MARROW CELLS; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELLS; OSTEOGENESIS; POLYGLUTAMIC ACID; RABBITS; SOX9 TRANSCRIPTION FACTOR; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

ADENOVIRIDAE; ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 79953026086     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.02.014     Document Type: Article

References (46)

1. Chen H., Sun J., Hoemann C.D., Lascau-Coman V., Ouyang W., McKee M.D., et al. Drilling and microfracture lead to different bone structure and necrosis during bone-marrow stimulation for cartilage repair. J Orthop Res 2009, 27:1432-1438.
2. Steadman J.R., Rodkey W.G., Briggs K.K. Microfracture to treat full-thickness chondral defects: surgical technique, rehabilitation, and outcomes. J Knee Surg 2002, 15:170-176.
3. LaPrade R.F., Swiontkowski M.F. New horizons in the treatment of osteoarthritis of the knee. JAMA 1999, 281:876-878.
4. Hunziker E.B. Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage 2002, 10:432-463.
5. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O., Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 1994, 331:889-895.
6. Buckwalter J.A., Mankin H.J. Articular cartilage repair and transplantation. Arthritis Rheum 1998, 41:1331-1342.
7. Tsuchiya H., Kitoh H., Sugiura F., Ishiguro N. Chondrogenesis enhanced by overexpression of sox9 gene in mouse bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun 2003, 301:338-343.
8. Nixon A.J., Haupt J.L., Frisbie D.D., Morisset S.S., McIlwraith C.W., Robbins P.D., et al. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy. Gene Ther 2005, 12:177-186.
9. Solchaga L.A., Penick K., Goldberg V.M., Caplan A.I., Welter J.F. Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. Tissue Eng Part A 2010, 16:1009-1019.
10. Hidaka C., Quitoriano M., Warren R.F., Crystal R.G. Enhanced matrix synthesis and in vitro formation of cartilage-like tissue by genetically modified chondrocytes expressing BMP-7. J Orthop Res 2001, 19:751-758.
11. Miljkovic N.D., Cooper G.M., Marra K.G. Chondrogenesis, bone morphogenetic protein-4 and mesenchymal stem cells. Osteoarthritis Cartilage 2008, 16:1121-1130.
12. Toh W.S., Liu H., Heng B.C., Rufaihah A.J., Ye C.P., Cao T. Combined effects of TGFbeta1 and BMP2 in serum-free chondrogenic differentiation of mesenchymal stem cells induced hyaline-like cartilage formation. Growth Factor 2005, 23:313-321.
13. Diao H., Wang J., Shen C., Xia S., Guo T., Dong L., et al. Improved cartilage regeneration utilizing mesenchymal stem cells in TGF-beta1 gene-activated scaffolds. Tissue Eng Part A 2009, 15:2687-2698.
14. Ju W., Hoffmann A., Verschueren K., Tylzanowski P., Kaps C., Gross G., et al. The bone morphogenetic protein 2 signaling mediator Smad1 participates predominantly in osteogenic and not in chondrogenic differentiation in mesenchymal progenitors C3H10T1/2. J Bone Miner Res 2000, 15:1889-1899.
15. van Beuningen H.M., Glansbeek H.L., van der Kraan P.M., van den Berg W.B. Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis Cartilage 2000, 8:25-33.
16. Kawamura K., Chu C.R., Sobajima S., Robbins P.D., Fu F.H., Izzo N.J., et al. Adenoviral-mediated transfer of TGF-beta1 but not IGF-1 induces chondrogenic differentiation of human mesenchymal stem cells in pellet cultures. Exp Hematol 2005, 33:865-872.
17. Steinert A.F., Proffen B., Kunz M., Hendrich C., Ghivizzani S.C., Noth U., et al. Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer. Arthritis Res Ther 2009, 11:R148.
18. Wright E., Hargrave M.R., Christiansen J., Cooper L., Kun J., Evans T., et al. The Sry-related gene Sox9 is expressed during chondrogenesis in mouse embryos. Nat Genet 1995, 9:15-20.
19. Bi W., Deng J.M., Zhang Z., Behringer R.R., de Crombrugghe B. Sox9 is required for cartilage formation. Nat Genet 1999, 22:85-89.
20. Ikeda T., Kawaguchi H., Kamekura S., Ogata N., Mori Y., Nakamura K., et al. Distinct roles of Sox5, Sox6, and Sox9 in different stages of chondrogenic differentiation. J Bone Miner Metab 2005, 23:337-340.
21. Bell D.M., Leung K.K., Wheatley S.C., Ng L.J., Zhou S., Ling K.W., et al. SOX9 directly regulates the type-II collagen gene. Nat Genet 1997, 16:174-178.
22. Zhang P., Jimenez S.A., Stokes D.G. Regulation of human COL9A1 gene expression. Activation of the proximal promoter region by SOX9. J Biol Chem 2003, 278:117-123.
23. Liu Y., Li H., Tanaka K., Tsumaki N., Yamada Y. Identification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2(XI) collagen gene. J Biol Chem 2000, 275:12712-12718.
24. Sekiya I., Tsuji K., Koopman P., Watanabe H., Yamada Y., Shinomiya K., et al. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem 2000, 275:10738-10744.
25. Tew S.R., Li Y., Pothacharoen P., Tweats L.M., Hawkins R.E., Hardingham T.E. Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes. Osteoarthritis Cartilage 2005, 13:80-89.
26. Cucchiarini M., Thurn T., Weimer A., Kohn D., Terwilliger E.F., Madry H. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor SOX9. Arthritis Rheum 2007, 56:158-167.
27. Smits P., Li P., Mandel J., Zhang Z., Deng J.M., Behringer R.R., et al. The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev Cell 2001, 1:277-290.
28. Ikeda T., Kamekura S., Mabuchi A., Kou I., Seki S., Takato T., et al. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum 2004, 50:3561-3573.
29. Kupcsik L., Stoddart M.J., Li Z., Benneker L.M., Alini M. Improving chondrogenesis: potential and limitations of SOX9 gene transfer and mechanical stimulation for cartilage tissue engineering. Tissue Eng Part A 2010, 16:1845-1855.
30. Dai K.R., Xu X.L., Tang T.T., Zhu Z.A., Yu C.F., Lou J.R., et al. Repairing of goat tibial bone defects with BMP-2 gene-modified tissue-engineered bone. Calcif Tissue Int 2005, 77:55-61.
31. Sun H., Wu C., Dai K., Chang J., Tang T. Proliferation and osteoblastic differentiation of human bone marrow-derived stromal cells on akermanite-bioactive ceramics. Biomaterials 2006, 27:5651-5657.
32. Fu L., Tang T., Miao Y., Zhang S., Qu Z., Dai K. Stimulation of osteogenic differentiation and inhibition of adipogenic differentiation in bone marrow stromal cells by alendronate via ERK and JNK activation. Bone 2008, 43:40-47.
33. Huang Y., Jin X., Zhang X., Sun H., Tu J., Tang T., et al. In vitro and in vivo evaluation of akermanite bioceramics for bone regeneration. Biomaterials 2009, 30:5041-5048.
34. Jiang Y., Chen L.K., Zhu D.C., Zhang G.R., Guo C., Qi Y.Y., et al. The inductive effect of bone morphogenetic protein-4 on chondral-lineage differentiation and in situ cartilage repair. Tissue Eng Part A 2010, 16:1621-1632.
35. Wakitani S., Goto T., Pineda S.J., Young R.G., Mansour J.M., Caplan A.I., et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Jt Surg Am 1994, 76:579-592.
36. Wakitani S., Goto T., Young R.G., Mansour J.M., Goldberg V.M., Caplan A.I. Repair of large full-thickness articular cartilage defects with allograft articular chondrocytes embedded in a collagen gel. Tissue Eng 1998, 4:429-444.
37. Steinert A.F., Noth U., Tuan R.S. Concepts in gene therapy for cartilage repair. Injury 2008, 39(Suppl. 1):S97-S113.
38. Cheng A., Genever P.G. SOX9 determines RUNX2 transactivity by directing intracellular degradation. J Bone Miner Res 2010, 25:2404-2413.
39. Kisiday J.D., Kopesky P.W., Evans C.H., Grodzinsky A.J., McIlwraith C.W., Frisbie D.D. Evaluation of adult equine bone marrow- and adipose-derived progenitor cell chondrogenesis in hydrogel cultures. J Orthop Res 2008, 26:322-331.
40. Li Z., Kupcsik L., Yao S.J., Alini M., Stoddart M.J. Chondrogenesis of human bone marrow mesenchymal stem cells in fibrin-polyurethane composites. Tissue Eng Part A 2009, 15:1729-1737.
41. Shapiro F., Koide S., Glimcher M.J. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J Bone Jt Surg Am 1993, 75:532-553.
42. Madry H., Kaul G., Cucchiarini M., Stein U., Zurakowski D., Remberger K., et al. Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther 2005, 12:1171-1179.
43. Guo X., Zheng Q., Yang S., Shao Z., Yuan Q., Pan Z., et al. Repair of full-thickness articular cartilage defects by cultured mesenchymal stem cells transfected with the transforming growth factor beta1 gene. Biomed Mater 2006, 1:206-215.
44. Bi W., Huang W., Whitworth D.J., Deng J.M., Zhang Z., Behringer R.R., et al. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci U S A 2001, 98:6698-6703.
45. Akiyama H., Lyons J.P., Mori-Akiyama Y., Yang X., Zhang R., Zhang Z., et al. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 2004, 18:1072-1087.
46. Wilson J.M. Adenoviruses as gene-delivery vehicles. New Engl J Med 1996, 334:1185-1187.